Clofibrate, a lipid lowering agent inhibits both cholesterol and triglyceride synthesis by:
Inhibiting HMG CoA reductase Binding to bile acids and preventing its reabsorption Inhibiting VLDL production Activating lipoprotein lipase, resulting in VLDL degradation